Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Undertreatment of Osteoporosis in Men Who Have Had a Hip Fracture

Undertreatment of Osteoporosis in Men Who Have Had a Hip Fracture Kiebzak et al1 should be congratulated on their efforts to highlight the undertreatment of osteoporosis in men who have had a hip fracture. Methodological constraints due to the retrospective collection of data are evident, particularly on their assessment of comorbidity and risk factors. But the poor rates of prefracture and postfracture osteoporosis treatment, particularly in men, will make for uncomfortable reading among orthopedic surgeons across the globe. These patients are often seen by orthopedic services on multiple occasions. Robinson et al2 have prospectively studied the rates of refracture in individuals who had previously experienced wrist, proximal humerus, ankle, or hip insufficiency fractures. Men older than 45 years were shown to be at significantly higher risk of insufficiency fractures compared with women (relative risk, 5.55 [men] vs 2.94 [women]). Interestingly, this increased risk was sustained in all age group cohorts from 45 to 85 years or older. Previous hip, wrist, and proximal humerus fractures all predisposed to subsequent hip fracture. Conversely, a previous hip fracture was also shown to be a risk factor for subsequent wrist, hip, or proximal humerus fracture. These findings indicate that those patients with hip fractures, and indeed other insufficiency fractures, are likely to require orthopedic surgical management for more than just the index injury. Osteoporosis treatment for the patient at risk is therefore an option that the orthopedic surgeon cannot safely ignore. The reluctance to institute fracture prevention pharmaceutical regimens is likely to be symptomatic of the paucity of evidence for their efficacy, particularly in the older insufficiency fracture population.3,4 Until the efficacy of bisphosphonates, calcium, vitamin D, and other agents in fracture prevention is clearly demonstrated in elderly patients, the findings of undertreatment by Kiebzak et al1 will remain prevalent. References 1. Kiebzak GMBeinart GAPerser KAmbrose CGSift SJHeggeness MH Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med. 2002;1622217- 2222Google ScholarCrossref 2. Robinson CMRoyds MAbraham ACourt-Brown CMChristie J Refractures in patients at least forty-five years old: a prospective analysis of twenty-two thousand and sixty patients. J Bone Joint Surg Am. 2002;841528- 1533Google ScholarCrossref 3. Gillespie WJAvenell AHenry DAO'Connell DLRobertson J Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis [Cochrane Review on CD-ROM]. Oxford, England Cochrane Library, Update Software2003; (issue 1) Available at: http://www.update-software.com/abstracts/ab000227.htm. Accessed January 4, 2003. 4. Cranney AWelch VAdachi JD et al. Etidronate for treating and preventing postmenopausal osteoporosis [Cochrane Review on CD-ROM]. Oxford, England Cochrane Library, Update Software2003; (issue 1) Available at: http://www.update-software.com/abstracts/ab003376.htm. Accessed January 4, 2003. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Undertreatment of Osteoporosis in Men Who Have Had a Hip Fracture

Abraham, Alwyn
Archives of Internal Medicine , Volume 163 (10) – May 26, 2003
Download PDF
1 page
Read Article

Undertreatment of Osteoporosis in Men Who Have Had a Hip Fracture

Abstract

Kiebzak et al1 should be congratulated on their efforts to highlight the undertreatment of osteoporosis in men who have had a hip fracture. Methodological constraints due to the retrospective collection of data are evident, particularly on their assessment of comorbidity and risk factors. But the poor rates of prefracture and postfracture osteoporosis treatment, particularly in men, will make for uncomfortable reading among orthopedic surgeons across the globe. These patients are often seen...
Loading next page...
 
/lp/american-medical-association/undertreatment-of-osteoporosis-in-men-who-have-had-a-hip-fracture-HDcikolfQC
Publisher
American Medical Association
Copyright
Copyright © 2003 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.163.10.1236-a
Publisher site
See Article on Publisher Site

Abstract

Kiebzak et al1 should be congratulated on their efforts to highlight the undertreatment of osteoporosis in men who have had a hip fracture. Methodological constraints due to the retrospective collection of data are evident, particularly on their assessment of comorbidity and risk factors. But the poor rates of prefracture and postfracture osteoporosis treatment, particularly in men, will make for uncomfortable reading among orthopedic surgeons across the globe. These patients are often seen by orthopedic services on multiple occasions. Robinson et al2 have prospectively studied the rates of refracture in individuals who had previously experienced wrist, proximal humerus, ankle, or hip insufficiency fractures. Men older than 45 years were shown to be at significantly higher risk of insufficiency fractures compared with women (relative risk, 5.55 [men] vs 2.94 [women]). Interestingly, this increased risk was sustained in all age group cohorts from 45 to 85 years or older. Previous hip, wrist, and proximal humerus fractures all predisposed to subsequent hip fracture. Conversely, a previous hip fracture was also shown to be a risk factor for subsequent wrist, hip, or proximal humerus fracture. These findings indicate that those patients with hip fractures, and indeed other insufficiency fractures, are likely to require orthopedic surgical management for more than just the index injury. Osteoporosis treatment for the patient at risk is therefore an option that the orthopedic surgeon cannot safely ignore. The reluctance to institute fracture prevention pharmaceutical regimens is likely to be symptomatic of the paucity of evidence for their efficacy, particularly in the older insufficiency fracture population.3,4 Until the efficacy of bisphosphonates, calcium, vitamin D, and other agents in fracture prevention is clearly demonstrated in elderly patients, the findings of undertreatment by Kiebzak et al1 will remain prevalent. References 1. Kiebzak GMBeinart GAPerser KAmbrose CGSift SJHeggeness MH Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med. 2002;1622217- 2222Google ScholarCrossref 2. Robinson CMRoyds MAbraham ACourt-Brown CMChristie J Refractures in patients at least forty-five years old: a prospective analysis of twenty-two thousand and sixty patients. J Bone Joint Surg Am. 2002;841528- 1533Google ScholarCrossref 3. Gillespie WJAvenell AHenry DAO'Connell DLRobertson J Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis [Cochrane Review on CD-ROM]. Oxford, England Cochrane Library, Update Software2003; (issue 1) Available at: http://www.update-software.com/abstracts/ab000227.htm. Accessed January 4, 2003. 4. Cranney AWelch VAdachi JD et al. Etidronate for treating and preventing postmenopausal osteoporosis [Cochrane Review on CD-ROM]. Oxford, England Cochrane Library, Update Software2003; (issue 1) Available at: http://www.update-software.com/abstracts/ab003376.htm. Accessed January 4, 2003.

Journal

Archives of Internal Medicine – American Medical Association

Published: May 26, 2003

Keywords: osteoporosis,hip fractures

References

  • Undertreatment of osteoporosis in men with hip fracture.
    Heggeness MH; Arch Intern Med.
  • Refractures in patients at least forty-five years old: a prospective analysis of twenty-two thousand and sixty patients.
    Christie J; J Bone Joint Surg Am.
  • Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis [Cochrane Review on CD-ROM].
    Robertson J
  • Etidronate for treating and preventing postmenopausal osteoporosis [Cochrane Review on CD-ROM].
    Adachi JD

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

Sign up
for free
Start 14 day
Free Trial